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Abstract
Purpose: COVID-19 is a novel, severely contagious and progressive infection occurring worldwide. The diagnosis of 
the disease is based on real-time polymerase chain reaction (RT-PCR) and computed tomography (CT) scan, even 
though they are still controversial methods. 
Material and methods: We studied 54 patients with suspected COVID-19 and the two mentioned methods were 
compared with each other.
Results: Sensitivity and specificity of the abnormal chest CT scan, ground-glass opacity (GGO), consolidation opacity, 
and both of GGO and consolidation were also surveyed based on RT-PCR. The results showed that RT-PCR assay 
was negative in 23 (42.6%) patients and positive in 31 (57.4%) cases. Also, the patients with an abnormal chest CT 
scan comprised 37 (68.5%). The sensitivity and specificity of abnormal CT scan were 78.6% and 42.3%, respectively, 
based on the RT-PCR method. 
Conclusions: Other techniques alongside CT scan and RT-PCR are advocated for accuracy of the COVID-19 diagnosis.
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Introduction
Seven years after the MERS epidemic in the world, a new 
disease has been identified in China that has been an-
nounced as an international emergency worldwide by the 
World Health Organization (WHO) [1]. Although China 
was originally the center of the disease, the virus quickly 
spread to many parts of the world, leading to tremendous 
mortality [2]. This novel virus belongs to the coronavi-
rus family causing flu-like symptoms as well as SARS and 
MERS. The most important forms of transmission are 
droplets and physical contact [3]. On February 11, 2020, 
the WHO named the new virus coronavirus disease 2019 
(COVID-19) [4]. The clinical manifestation of the disease 
include fever, cough and dyspnea representing pneu-
monia, acute respiratory syndrome and death in severe 
disease [5]. The risk factors of infection include diabetes 
mellitus, hypertension, and cardiovascular disease [6,7]. 
The number of COVID-19 patients is still rising, with 
22,524,291 infected worldwide on April 22, 2020 [8].
The gold standard test for the disease is known as 
real-time polymerase chain reaction (RT-PCR) assay, but 
false-negative results may be reported due to the low viral 
load of samples and manner of sampling. On the other 
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hand, the chest computed tomography (CT) scan is em-
ployed as an important diagnostic supplement to verify 
the COVID-19 disease [9]. The advantages of this method 
are being more time-saving than RT-PCR [10], and high 
sensitivity (97%) in early diagnosis [11-13]. Neverthe-
less, positive RT-PCR may occur in normal chest CT in 
COVID-19 patients [14]. Furthermore, the chest CT scans 
of COVID-19 patients have shown low positive predictive 
value [15].
According to the rapid spread of the disease and the 
importance of preventing and controlling COVID-19, 
the primary diagnosis is crucial. This study was conducted 
to compare between CT scan and RT-PCR test in patients 
suspected to have COVID-19 infection. Sensitivity and 
specificity of CT scan were also evaluated based on RT-PCR.
Material and methods
This study was a cross sectional design on patients with 
COVID-19 admitted to Vali-e-Asr Fasa Hospital. Sensitivity 
and specificity of the chest CT scan, and oropharyngeal and 
nasopharyngeal RT-PCR were considered in 54 suspected 
COVID-19 patients. Demographic information including sex 
and age was also collected. Chest CT scan results were cat-
egorized as ground-glass, consolidation and normal. Cohen’s 
kappa coefficient was considered for RT-PCR and CT scan.
Results
Of 54 patients, 27 (50%) were female and half were male, 
with the mean age range of 51.75 ± 18.63. 
Table 1. Results of real-time polymerase chain reaction (RT-PCR), chest computed tomography (CT) scan and also sensitivity and specificity of chest CT scan 
based on RT-PCR test are presented for diagnosis of COVID-19 
Variable RT-PCR results k p-value
Negative number (%) Positive number (%)
Ground glass opacity
No 14 (25.9) 9 (16.7) 0.218 0.1






No 17 (31.5)  18 (33.3) 0.011 0.933





Ground glass and consolidation
No 11 (36.7)  6 (20.0) 0.167 0.09






No 11 (20.2)  6 (11.1) 0.211 0.09
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RT-PCR assay was carried out on the 54 suspected 
COVID-19 patients with the subsequent result of 23 (42.6%) 
negative and 31 (57.4%) positive cases.
The patients with an abnormal chest CT scan com-
prised 37 (68.5%), while normal chest CT results were 
obtained in 17 (31.5%) of the patients. 23/54 (42.6%) pa-
tients showed ground-glass opacity (GGO), while 28/54 
(51.85%) cases were with consolidation opacities. Patients 
demonstrating both GGO and consolidation opacities 
comprised 13/54 (24.1%) in chest CT scan. 
The sensitivity and specificity of chest CT scan based 
on the RT-PCR test (as a gold standard) for COVID-19 
are presented in Table 1. The sensitivity and specificity of 
abnormal CT scan were 78.6% and 42.3%, respectively, 
based on the RT-PCR method. In the cases with GGO, 
the sensitivity and specificity of CT scan were calculated 
as 67.9% and 53.8% respectively, whilst CT scan findings 
of consolidated lungs showed 35.7% sensitivity and 65.4% 
specificity based on RT-PCR. These amounts were 53.8% 
sensitivity and 64.7% specificity for the simulations of 
GGO and consolidation opacities in suspected COVID-19 
patients. CT scan images according to PCR findings are 
presented in Figure 1.
Discussion
Analyzed data of 54 (f = m) suspected COVID-19 pa-
tients, 42.6% (n = 23) showed GGO on chest CT; 57.4% 
(n = 31) had consolidation, 24.1% had both and only 
16.6% had normal chest CT findings. 87.4% of the sus-
pected cases tested positive in RT-PCR, reporting as the 
principal and accepted method in diagnosing COVID-19. 
Our data on sensitivity and specificity of ground glass 
opacity showed 67.9% and 53.8% respectively (k = 0.218). 
For chest CT with only consolidation, the sensitivity was 
35.7% with the specificity of 65.4% (k = 0.11), and for the 
both GGO and consolidation the sensitivity and specific-
ity were found to be 53.8% and 64.7% respectively in di-
agnosing COVID-19, based on RT-PCR.
Data on the correlation of chest CT and RT-PCR in 
COVID-19 diagnosis are located at the two extremes. 
Some studies, especially those from the radiology com-
munity, support a pivotal role for chest CT in diagnos-
ing COVID-19. A report of 1014 patients from China 
propos ed 97% sensitivity and specificity of 25% of CT 
scans based on RT-PCR results [11]. Another study from 
Wuhan, China, tried to determine the misdiagnosis rate of 
Figure 1. A) Ground-glass opacity (GGO) feature in computed tomography (CT) scan and polymerase chain reaction (PCR) positive case. B) GGO consolidation 
in CT scan and PCR positive case. C) GGO in CT scan and PCR negative case. D) GGO consolidation and PCR negative case
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C D
 Sensitivity and specificity of chest CT scan based on RT-PCR in COVID-19 diagnosis
e77© Pol J Radiol 2021; 86: e74-e77
chest CT; among 51 confirmed cases of COVID-19, 3.9% 
were found to be missed diagnoses. They suggested the 
use of chest CT as the standard method for screening and 
diagnosis of the disease [16]. Predominant findings in the 
CT scan of suspected patients were ground glass opacities 
and consolidation, local and bilateral patchy shadowing, 
and also crazy-paving patterns detected and associated 
with the disease [17-19]. 
In the extremely progressive outbreak of the COVID-19 
pandemic, an accessible, accurate, sensitive, and specific 
diagnostic method is crucial. However, the RT-PCR kits, 
despite their high specificity and acceptable sensitivity, are 
not accessible worldwide. Chest CT scans, based on prom-
ising reports mostly from China, have been advocated, 
but are criticized. It is suggested that the CT findings of 
COVID-19 lack sufficient specificity to the disease, and 
they have been seen in a variety of infectious and nonin-
fectious conditions. High specificity reports of CT scan 
in China may be due to the high incidence, while they are 
likely to be different in other regions with a lower inci-
dence of the disease. Meanwhile, in seasonal flu (ground 
glass opacity and consolidation as chest patterns of diag-
nosis as well as H1N1 influenza, MERS, and SARS), the 
sensitivity of the chest CT scan would not be accurate 
enough. However, the criticizers also reported some scien-
tific flaws in the previous discussed articles. The American 
College of Radiology and the Centers for Disease Con-
trol do not currently suggest chest CT for diagnosis of 
COVID-19 [20-22].
We suggest that a proper diagnosis of COVID-19 
should be based on a mixture of clinical manifestation, 
nucleotide viral testing, history of contact and occupa-
tional and social exposure. Other techniques alongside 
CT scan and RT-PCR are also advocated for accuracy of 
the disease diagnosis. Moreover, considering the low di-
agnostic value of the chest CT scan may help the health 
care providers to determine the severity and course of the 
disease. 
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